021-51111890
购物车（）
sales@molnova.cn
Selegiline hydrochloride
CAS No. 14611-52-0
Selegiline hydrochloride ( R(-)-Deprenyl hydrochloride )
产品货号. M19873 CAS No. 14611-52-0
Selegiline hydrochloride is a selective reversible inhibitor of MAO-B (Ki = 0.091 μM) over MAO-A (Ki = 9.06 μM). Monoamine oxidase (MAO) inhibitors have utility in ameliorating a variety of neurological conditions including depression.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥476 | 有现货 |
|
| 10MG | ￥662 | 有现货 |
|
| 25MG | ￥1050 | 有现货 |
|
| 50MG | ￥1473 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Selegiline hydrochloride
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Selegiline hydrochloride is a selective reversible inhibitor of MAO-B (Ki = 0.091 μM) over MAO-A (Ki = 9.06 μM). Monoamine oxidase (MAO) inhibitors have utility in ameliorating a variety of neurological conditions including depression.
-
产品描述Selegiline hydrochloride is a selective reversible inhibitor of MAO-B (Ki = 0.091 μM) over MAO-A (Ki = 9.06 μM). Monoamine oxidase (MAO) inhibitors have utility in ameliorating a variety of neurological conditions including depression.
-
同义词R(-)-Deprenyl hydrochloride
-
通路Angiogenesis
-
靶点ALK
-
受体MAO-B
-
研究领域Neurological Disease
-
适应症Early Parkinson's disease
化学信息
-
CAS Number14611-52-0
-
分子量223.74
-
分子式C13H18ClN
-
纯度>98% (HPLC)
-
溶解度DMSO: 30 mg/mL;Water: 20 mg/mL;Ethanol: 30 mg/mL
-
SMILESCl.C[C@H](Cc1ccccc1)N(C)CC#C
-
化学全称(2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine;hydrochloride
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Wimbiscus M et al. MAO inhibitors: risks benefits and lore. Cleve Clin J Med. 2010 Dec;77(12):859-82.
产品手册
关联产品
-
N-((4-([1,2,4]triazo...
Compound 12d is a potent ALK5 inhibitor with an IC50 of 7nM.
-
GSK1838705A
GSK1838705A is a potent, specific inhibitor of IGF-IR and insulin receptor (IR) with IC50 of 2.0 and 1.6 nM.
-
Selegiline hydrochlo...
Selegiline hydrochloride is a selective reversible inhibitor of MAO-B (Ki = 0.091 μM) over MAO-A (Ki = 9.06 μM). Monoamine oxidase (MAO) inhibitors have utility in ameliorating a variety of neurological conditions including depression.
